astragaloside a has been researched along with Age-Related Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, B; Gao, J; Liu, XL; Sun, NY; Wu, XH | 1 |
| Du, J; Jin, H; Ren, H; Wang, W; Yang, G | 1 |
2 other study(ies) available for astragaloside a and Age-Related Osteoporosis
| Article | Year |
|---|---|
Astragaloside‑IV modulates NGF‑induced osteoblast differentiation via the GSK3β/β‑catenin signalling pathway.
Topics: Cell Differentiation; Cell Proliferation; Cells, Cultured; Gene Expression Regulation; Glycogen Synthase Kinase 3 beta; Humans; Mesenchymal Stem Cells; Nerve Growth Factor; Osteogenesis; Osteoporosis; Saponins; Triterpenes; Wnt Signaling Pathway | 2021 |
Astragaloside IV protects against iron loading-induced abnormal differentiation of bone marrow mesenchymal stem cells (BMSCs).
Topics: Adipogenesis; Animals; Bone Marrow Cells; Cell Differentiation; Cell Proliferation; Cell Survival; Disease Models, Animal; Female; Homeostasis; Iron; Mesenchymal Stem Cells; Mice; Osteogenesis; Osteoporosis; Saponins; Triterpenes; X-Ray Microtomography | 2021 |